-+ 0.00%
-+ 0.00%
-+ 0.00%

Boule Diagnostics to Shut Down Instrument Business Amid Strategic Refocus

MT Newswires·11/04/2026 06:02:08
Listen to the news
06:02 AM EST, 11/04/2026 (MT Newswires) -- Boule Diagnostics (BOUL.ST) will discontinue its instrument business as it shifts its focus to its more profitable consumables, service, and OEM Clinical Diagnostic Solutions, or OEM CDS, operations. The shutdown is expected to reduce Boule's expenses by 90 million kronor to 100 million kronor per year starting in 2028, according to a Wednesday release. It involves workforce reductions within the Diagnostics division, subject to negotiations with relevant trade unions. The diagnostics company added that the move will not impact its OEM CDS business and reagent production operations in Spånga, Sweden.